查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434487

大麻测试（产品测试）：全球市场占有率分析、行业趋势和统计、成长趋势预测（2024-2029）

Global Cannabis Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年全球大麻测试市场规模预计为11.1亿美元，预计到2029年将达到20.5亿美元，在预测期内（2024-2029年）增长13.12%，以复合年增长率增长。

全球大麻测试 - 市场

COVID-19对该行业的影响仍在调查中。另一方面，由于新型冠状病毒感染疾病（COVID-19）导致的封锁，世界各地关闭了非必要的实验室和测试设施，大麻测试设备和服务的销售额略有下降。不过，也有一些正面的消息。 2020 年 4 月，两家以色列公司 Eibna 和 CannaSoul 联手申请了用于感染疾病COVID-19 的大麻萜烯配方专利。这些公司正在研究大麻萜烯製剂的有效性，该製剂用于治疗各种发炎疾病，包括由 COVID-19 引起的细胞激素感染疾病症候群。该领域合作和研究的增加可能会产生对大麻测试服务以分离新化合物的需求。

推动市场成长的主要因素是医用大麻使用的核准不断增加。大麻用于医疗目的的合法使用正在稳步增加，但各国根据其使用、分销、种植和消费的医学适应症而有所不同。此外，越来越多的研究支持将大麻用于医疗目的，一些研究表明大麻是对抗鸦片类药物流行的潜在手段。北美、欧洲和南美洲多个国家的政府机构已根据严格的标准，完全或以某种形式有限地使医用大麻的使用合法化。世界上大约有 40 个国家允许透过处方笺合法使用大麻或作为阿育吠陀药物有限使用。自 2018 年美国农业法案通过以来，已有支持使用大麻产品的法律。该法案允许广泛种植大麻，但仅限于一项试点计划，以衡量市场对大麻衍生产品的兴趣。该法案明确授权大麻衍生产品跨州转移用于商业或其他目的。此外，只要大麻衍生产品以合法方式生产，其销售、运输或拥有就不受限制。 2021年2月，美国立法者表示，他们正在计划制定新的立法，以废除联邦对大麻的禁令，大麻在许多州已经在一定程度上合法化。这些努力可能会对大麻检测设备的需求产生正面影响。随着基于大麻的产品变得更加法律规章并受到立法的约束，预计在研究期间对测试设备的需求将会增加。

大麻萃取物也用于治疗许多神经病变和精神疾病。随着这些疾病发病率的增加以及大麻使用和产量的增加，预计大麻测试市场在预测期内也会成长。据欧洲脑理事会称，截至 2022 年，全球将报告约 600 例神经病变病例，使精神障碍成为全球疾病和残疾的主要原因。忧郁症是最常见的精神障碍。全球范围内，超过 2.64 亿各年龄层的人患有忧郁症。患有忧郁症的女性多于男性。此外，大麻测试实验室对软体服务的认识和采用的提高也是推动市场发展的因素。

各个主要市场相关人员最近采取的大麻测试措施可能会进一步加速市场成长。例如，2022 年 9 月，2021 年推出的第三方大麻和大麻测试机构 Method Testing Labs 在佛罗里达州布兰登开设了一家位于佛罗里达州的实验室。预计此类活动将进一步推动市场成长。

然而，大麻检测设备的高成本是市场成长的主要障碍。

大麻测试市场趋势

分析仪器领域主导市场

COVID-19 对分析仪器的影响是正面的。总体而言，COVID-19感染疾病大流行显着增加了分析仪器的产量，并增加了对分析仪器的需求。此外，大麻萃取物也用于医学研究，因此在大流行期间对这些设备的需求持续存在。最后，美国许多地区都赋予大麻药局「基本业务」的称号。因此，这些发展预计将对市场开拓产生正面影响。

应测试大麻萃取物的重金属、效力、农药、萜烯成分、残留溶剂、水分、微生物和真菌生长以及霉菌毒素/黄曲毒素。测试可确保您的产品安全，同时产生收益和投资收益。 HPLC、气相层析法、液相层析法等仪器被广泛使用。 2021 年 6 月发表在《色谱杂誌 A》上的报导“使用液相层析法和超临界流体层析进行大麻素效力测试：我们在哪里，我们需要什么”的文章中，紫外线检测和高效液相层析被指示。超临界流体层析（SFC）对于大麻产品的准确效力测试非常有价值。

层析法技术广泛用于减少污染物。这些产品具有成本效益，同时可以有效去除大麻和大麻萃取物中的杀菌剂、杀虫剂、除草剂、增效剂和重金属等污染物。层析法也可用于降低大麻萃取物中四氢大麻酚 (THC) 的含量。这些用于从大麻萃取物中分离大麻素，例如大麻二酚 (CBD)、THC、大麻酚 (CBN) 和大麻醇 (CBG)。许多公司，例如 Sorbent Technologies Inc.，提供自己的基于层析法的测试和提取产品。本公司销售吸附剂、薄层层析法（ TLC）板、快速管柱、快速层析法系统、快速蛋白液相层析法（FPLC）管柱、高效液相层析（HPLC）管柱、气相层析法（GC）管柱等。层析法产品。 、凝胶过滤、固相萃取 (SPE) 管柱和针筒筛检程式。许多其他公司也提供各种产品，包括 Aurum Labs、WATERS 和 CannaSafe Inc。领先企业的出现预计将推动市场成长，因为它会带来更好的产品可用性。

此外，主要市场参与者在预测期内支持市场的成长。 2021 年 3 月，PerkinElmer 推出了业界首款经过认证的标准物质 (CRM) 试剂和耗材套件，以简化大麻农药测试工作流程。此类产品将有助于促进使用分析仪器对大麻产品进行分析，并可能在预测期内进一步促进该领域的成长。

北美主导市场，预计在预测期内也是如此

预计北美将在整个预测期内主导整个市场。市场的成长得益于慢性病的高盛行率、有利的立法以及大公司在该地区的存在等因素。

根据加拿大政府2022年4月发表的报导，加拿大目前有超过9万40岁以上的人患有帕金森氏症。根据美国国家神经病变和中风研究所2022年7月更新的帕金森氏症资料，美国约有50万人被诊断出患有帕金森氏症，但一些专家由于未确诊或误诊疾病的问题，估计更多人患有帕金森氏症。超过一百万美国人患有帕金森氏症但没有报告。从大麻中提取的 CBD 产品用于治疗帕金森氏症等一些神经系统疾病的症状。如此高的发病率预计将对市场成长产生积极影响。

加拿大是世界上最早将大麻生产和使用合法化的国家之一。 2019年10月，该公司修订了法律，制定了三类新大麻的合法生产和销售规则，包括食用大麻、大麻萃取物和大麻外用药。这些产品需要先进的精製和测试设备从大麻植物中提取。因此，像加拿大这样的监管变化预计将对市场开拓产生积极影响。

此外，领先公司之间不断增加的合作和研究活动也是预计推动市场成长的一些因素。由于其支持性医疗政策和庞大的患者人数，美国预计将在该地区占据最大份额。 2022 年 8 月，SC Labs 将更名为 Agricor、Botanacor 和 Can-Lab，成为 SC Labs 名下的一家公司，在加州、密西根州、奥勒冈和科罗拉多提供无缝大麻测试服务。我们还在全国范围内提供大麻测试能力。预计此类行动将在预测期内推动市场成长。

大麻测试产业概述

大麻测试市场适度整合，由几家大公司组成。目前主导市场的公司包括安捷伦科技公司、岛津科学仪器公司、默克公司、Restek公司、珀金埃尔默公司、丹纳赫公司、Accelerated Technology Laboratories Inc.、Steep Hill Halent Laboratories Inc.、Digipath Inc.和Pharmlabs。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 市场概况
  • 市场驱动因素
    • 用于各种医疗目的的大麻合法化
    • 人们越来越认识到大麻用于治疗神经系统疾病
  • 市场限制因素
    • 分析设备高成本
  • 波特五力分析
    • 新进入者的威胁
    • 买家/消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度

第五章市场区隔（市场规模：金额）

  • 按产品、软体/服务
    • 分析设备
    • 分光装置
    • 消耗品
    • 大麻测试软体和服务
  • 按类型
    • 效力测试
    • 萜烯分析
    • 残留溶剂筛检
    • 重金属测试
    • 霉菌毒素测试
    • 其他类型
  • 按最终用户
    • 研究机构
    • 大麻药品製造商和药房
    • 其他最终用户
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区
    • 中东/非洲
      • GCC
      • 南非
      • 其他中东和非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区

第六章 竞争形势

  • 公司简介
    • Agilent Technologies Inc.
    • Shimadzu Scientific Instruments
    • Merck KGaA（Sigma Aldrich）
    • Restek Corporation
    • PerkinElmer Inc.
    • Danaher Corporation
    • Accelerated Technology Laboratories Inc.
    • Steep Hill Halent Laboratories Inc.
    • Digipath Inc.
    • Pharmlabs LLC
    • Sartorius AG
    • AB Sciex Pte. Ltd

第七章 市场机会及未来趋势

简介目录
Product Code: 67867

The Global Cannabis Testing Market size is estimated at USD 1.11 billion in 2024, and is expected to reach USD 2.05 billion by 2029, growing at a CAGR of 13.12% during the forecast period (2024-2029).

Global Cannabis Testing - Market

The impact of COVID-19 on this industry is still being studied. On one hand, due to the shutdown of non-essential labs and testing facilities across the world in response to COVID-19-induced lockdowns, sales of cannabis testing equipment and services were a bit low. However, there has been positive news too. In April 2020, two Israel-based companies, Eybna and CannaSoul, collaborated to work on a patented cannabis terpene formulation for treating COVID-19. The companies are examining the efficacy of the cannabis terpene formulation, which is being used to treat a diverse range of inflammatory conditions, including the cytokine storm syndrome caused by COVID-19. Collaborations and increased research in this segment are likely to create demand for cannabis testing services to isolate novel compounds.

The major factor attributing to the growth of the market is the increasing approval for the use of medical cannabis. The legal usage of cannabis for medical purposes is steadily growing but varies across countries based on the possession, distribution, cultivation, and medical indications for its consumption. In addition, there is an increasing volume of research supporting the use of marijuana for medical purposes, while some studies demonstrated it to be a potential means of fighting the opioid epidemic. Government bodies of several countries across North America, Europe, and South America have legalized the use of medicinal marijuana completely or for limited usage in certain forms on a strict basis. Globally, there are about 40 countries that allow the legal use of marijuana that is distributed through prescription or limited use in ayurvedic medicines. The use of hemp-based products has seen favorable legislation since the passage of the United States Farm Bill in 2018. The bill allowed the broad-based cultivation of hemp while restricting it to pilot programs for studying market interest in hemp-derived products. The bill explicitly allowed the transfer of hemp-derived products across state lines for commercial or other purposes. Additionally, it puts no restrictions on the sale, transport, or possession of hemp-derived products, so long as those items are produced in a manner consistent with the law. In February 2021, lawmakers in the United States stated that they were planning new legislation that would end the federal prohibition on marijuana, which has been legalized to some degree by many states. These initiatives are likely to impact the demand for cannabis testing equipment in a positive manner. As cannabis-based products find increased legislation and come under the ambit of law, the demand for testing equipment is expected to increase during the study period.

Cannabis extracts are also used to treat many neurological and mental disorders. As the incidence of these disorders increases, along with the increase in use and production of cannabis, the cannabis testing market is also expected to grow during the forecast period. According to the European Brain Council, as of 2022, approximately 600 neurological disorders reported around the world, placing mental disorders among the leading causes of ill-health and disability globally. Depression is the most common mental disorder. Globally, more than 264 million people of all ages suffer from depression. More women are affected by depression than men. Furthermore, growing awareness and adoption of software services in labs testing cannabis are other factors boosting the market.

The recent initiatives in cannabis testing by various key market players are likely to add to the market growth. For instance, in September 2022, Method Testing Labs, a third-party cannabis and hemp testing facility launched in 2021, opened a Florida-based lab located in Brandon, Florida. Such activities are expected to add to the market growth.

However, the high cost involved in cannabis testing instruments is a major drawback of the market growth.

Cannabis Testing Market Trends

The Analytical Instruments Segment is Dominating the Market

The COVID-19 impact on analytical instruments has been positive. In general, due to the COVID-19 pandemic, there has been an increase in demand for analytical instruments as the production of equipment has increased significantly. Additionally, since cannabis extracts are being used for medical research, there has been sustained demand for these equipment even during the pandemic. Finally, many regions in the United States tagged cannabis dispensaries with the title of 'essential business'. Thus, these developments are expected to positively affect the market development.

Cannabis extracts need to be tested for heavy metals, potency, pesticides, terpene profile, residual solvents, moisture, microbial and fungal growth, and mycotoxins/aflatoxin. Testing makes sure that the products are safe, while concurrently generating revenues and a return on investment. Instruments like HPLC, gas chromatography, and liquid chromatography are used extensively. An article titled 'Potency testing of cannabinoids by liquid and supercritical fluid chromatography: Where we are, what we need' published in the Journal of Chromatography A in June 2021 indicated that potency testing by high-performance liquid chromatography (HPLC) with UV detection and supercritical fluid chromatography (SFC) has been highly beneficial in the accurate potency testing of cannabis products..

Chromatography techniques are used extensively for contaminant reduction. They can be cost-effective while efficiently removing contaminants like fungicides, pesticides, herbicides, synergists, and heavy metals from cannabis and hemp extracts. Chromatography can also be used for reducing tetrahydrocannabinol (THC) content in cannabis extracts. They are used to separate cannabinoids like Cannabidiol (CBD), THC, Cannabinol (CBN), Cannabigerol (CBG), etc., from cannabis extracts. Many companies like Sorbent Technologies Inc. offer exclusive chromatography-based testing and extraction products. The company manufactures dedicated chromatographic products like Adsorbents, Thin-layer chromatography (TLC) Plates, Flash Cartridges, Flash Chromatographic Systems, Fast protein liquid chromatography (FPLC) Columns, High-performance liquid chromatography (HPLC) Columns, Gas Chromatography (GC) Columns, Gel Filtration, Solid Phase Extraction (SPE) Cartridges, and Syringe Filters. Many other companies like Aurum Labs, WATERS, and CannaSafe Inc., among others, offer diversified products too. The presence of major companies is expected to boost the market growth as it leads to greater product availability.

Also, the key market players are aiding in the market growth over the forecast period. In March 2021, PerkinElmer launched industry-first Certified reference material (CRM) reagent and consumable kit to streamline cannabis pesticide testing workflows. Such products aid in the easier analysis of the cannabis products using the analyzing instruments, which is likely to add to the segmental growth over the forecast period.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America is expected to dominate the overall market throughout the forecast period. The market growth is due to factors such as the high prevalence of chronic diseases in the region, favorable legislation, and the presence of large companies.

According to the article by the Government of Canada released in April 2022, over 90,000 people in Canada over the age of 40 years were living with Parkinson's disease as of date. As per the National Institute of Neurological Disorders and Stroke data on Parkinson's disease updated in July 2022, around 500,000 people in the United States were reported to be diagnosed with Parkinson's, however, some experts estimate that over 1 million Americans have Parkinson's disease and are unreported due to undiagnosed or misdiagnosis problems. Cannabis-derived CBD products are used to treat some symptoms of neurological disorders like Parkinson's. Such high incidence rates are expected to have a positive effect on market growth.

Canada was one of the first countries in the world to legalize the production and use of cannabis. In October 2019, it updated its laws to establish rules for the legal production and sale of three new classes of cannabis, which included edible cannabis, cannabis extracts, and cannabis topicals. These products need advanced purification and testing equipment for their extraction from cannabis sativa plants. Thus, regulatory changes like the one in Canada are expected to have a positive effect on the market development.

Furthermore, collaborations between major companies and an increase in the number of research efforts are some of the factors expected to drive the market growth. In this region, the United States is expected to have the maximum share due to supportive healthcare policies and the high number of patients. In August 2022, SC Labs rebranded Agricor, Botanacor, and Can-Lab to become one company under the SC Labs name, which offers seamless testing services for cannabis across California, Michigan, Oregon, and Colorado, as well as hemp testing capabilities nationwide. Such actions are expected to boost the market growth over the forecast period.

Cannabis Testing Industry Overview

The cannabis testing market is moderately consolidated and consists of some major players. Some of the companies currently dominating the market are Agilent Technologies Inc., Shimadzu Scientific Instruments, Merck KGaA, Restek Corporation, PerkinElmer Inc., Danaher Corporation, Accelerated Technology Laboratories Inc., Steep Hill Halent Laboratories Inc., Digipath Inc., and Pharmlabs LLC.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Legalization of Cannabis for Various Medical Purposes
    • 4.2.2 Increasing Awareness regarding Cannabis for Treating Neurological Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Analytical Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product and Software/Service
    • 5.1.1 Analytical Instruments
    • 5.1.2 Spectroscopy Instruments
    • 5.1.3 Consumables
    • 5.1.4 Cannabis Testing Software and Services
  • 5.2 By Type
    • 5.2.1 Potency Testing
    • 5.2.2 Terpene Profiling
    • 5.2.3 Residual Solvent Screening
    • 5.2.4 Heavy Metal Testing
    • 5.2.5 Mycotoxin Testing
    • 5.2.6 Other Types
  • 5.3 By End User
    • 5.3.1 Laboratories
    • 5.3.2 Cannabis Drug Manufacturers and Dispensaries
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Shimadzu Scientific Instruments
    • 6.1.3 Merck KGaA (Sigma Aldrich)
    • 6.1.4 Restek Corporation
    • 6.1.5 PerkinElmer Inc.
    • 6.1.6 Danaher Corporation
    • 6.1.7 Accelerated Technology Laboratories Inc.
    • 6.1.8 Steep Hill Halent Laboratories Inc.
    • 6.1.9 Digipath Inc.
    • 6.1.10 Pharmlabs LLC
    • 6.1.11 Sartorius AG
    • 6.1.12 AB Sciex Pte. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS